Ablation of PARP16 rescued cardiac dysfunction and ameliorated TAC-induced cardiac hypertrophy and fibrosis in mice, as well as PE-induced cardiomyocyte hypertrophic responses in vitro. This evidence concerns the gene PARP16 and cardiac hypertrophy.